Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 2021.00 34.25 (1.72%) | NSE 2015.90 30.30 (1.53%) | Trade | Add

BSE Live

Jan 30, 16:01

2021.00 34.25 (1.72%)

Volume

AVERAGE VOLUME

5-Day

18,760

10-Day

16,880

30-Day

15,759

12,564

Prev. Close

1986.75
Open Price

1975.05

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 30, 15:57

2015.90 30.30 (1.53%)

Volume

AVERAGE VOLUME

5-Day

459,451

10-Day

421,766

30-Day

542,631

554,016

Prev. Close

1985.60
Open Price

1978.70

Bid Price (Qty.)
2015.90 (586)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Glenmark Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	28.22	28.22	28.22	28.22	28.22
Total Share Capital	28.22	28.22	28.22	28.22	28.22
Reserves and Surplus	8,821.22	7,801.48	9,445.71	9,058.43	7,036.41
Total Reserves and Surplus	8,821.22	7,801.48	9,445.71	9,058.43	7,036.41
Total Shareholders Funds	8,849.44	7,847.93	9,473.92	9,086.65	7,064.63
Minority Interest	-0.37	-0.38	365.34	351.47	-0.35
NON-CURRENT LIABILITIES
Long Term Borrowings	512.70	0.00	3,852.14	2,571.74	3,888.82
Deferred Tax Liabilities [Net]	58.59	0.28	42.95	31.50	28.75
Other Long Term Liabilities	662.17	692.21	591.80	352.50	420.72
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	1,233.46	692.49	4,486.89	2,955.74	4,338.28
CURRENT LIABILITIES
Short Term Borrowings	1,681.50	990.60	495.58	1,098.61	798.61
Trade Payables	2,579.53	2,535.93	2,391.86	2,288.66	2,237.77
Other Current Liabilities	1,109.92	1,650.94	1,650.54	810.78	650.31
Short Term Provisions	596.08	641.12	507.55	491.38	514.33
Total Current Liabilities	5,967.02	5,818.59	5,045.53	4,689.43	4,201.02
Total Capital And Liabilities	16,049.55	14,358.62	19,371.68	17,083.29	15,603.58
ASSETS
NON-CURRENT ASSETS
Tangible Assets	3,319.37	3,118.15	3,904.16	3,690.63	2,957.78
Intangible Assets	1,097.19	1,024.65	2,224.61	2,136.60	2,113.06
Capital Work-In-Progress	541.99	419.32	1,115.18	921.09	1,217.79
Fixed Assets	5,251.39	4,804.68	7,380.02	6,837.10	6,452.51
Non-Current Investments	56.36	789.66	44.65	49.62	24.63
Deferred Tax Assets [Net]	1,124.11	1,049.72	1,805.91	1,686.12	1,534.67
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	251.97	219.11	193.75	168.08	174.18
Total Non-Current Assets	6,754.09	6,930.54	9,497.96	8,800.94	8,244.00
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	3,028.53	2,513.05	2,977.79	2,499.83	2,276.83
Trade Receivables	3,341.95	1,858.41	4,098.61	3,101.14	2,572.06
Cash And Cash Equivalents	1,705.23	1,659.46	1,469.70	1,411.52	1,139.16
Short Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
OtherCurrentAssets	1,219.76	1,397.16	1,327.63	1,269.87	1,371.53
Total Current Assets	9,295.47	7,428.08	9,873.72	8,282.35	7,359.58
Total Assets	16,049.55	14,358.62	19,371.68	17,083.29	15,603.58
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	936.54	1,193.96	477.58	559.75	544.81
BONUS DETAILS
Bonus Equity Share Capital	15.84	15.84	15.84	15.84	15.84
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.07	0.05	0.07
Non-Current Investments Unquoted Book Value	0.00	0.00	44.58	49.58	24.56
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00